Skip to main navigation Skip to search Skip to main content

Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model

  • Kai Dai*
  • , Yabing Huang
  • , Zubing Chen
  • , Xiaomei Sun
  • , Lihua Yang
  • , Yingan Jiang*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Natural killer cell (NK cell)-based immunotherapy is a promising therapeutic strategy for hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying the regulation of NK cell function in the tumor sites are not completely elucidated. In this study, we identified the enhanced expression of kelch repeat and BTB (POZ) domain containing 2(Kbtbd2) in intratumoral NK cells in a mouse HCC implantation model as a negative regulator of NK cells. To investigate this interaction, we used a Tet-on inducibleexpression system to control Kbtbd2 expression in an immortalized mouse NK cell line KIL C.2. With this approach, we found that overexpression of Kbtbd2 reduced KIL C.2 cell proliferation, decreased expression certain of Ly49 receptor family members, and substantially impaired cytotoxic activity of KIL C.2 cells in vitro. Moreover, phosphorylation of mTOR and its target 4E-binding protein 1 was reduced in Kbtbd2-expressing KIL C.2 cells, along with down-regulated phosphorylation of Erk1/2. Adoptively transferred Kbtbd2-expressing KIL C.2 cells exhibited weaker tumoricidal effect on hepatocellular carcinoma cells in the HCC implantation model, in comparison with transferred control KIL C.2 cells. Taken together, our investigation indicates that Kbtbd2 is an inhibitory molecule for the tumoricidal activity of KIL C.2 cells and perhaps intratumoral NK cells.
Original languageEnglish
Pages (from-to)683-695
Number of pages13
JournalEuropean Journal of Immunology
Volume48
Issue number4
DOIs
StatePublished - Apr 2018

Funding

This study was supported by Chinese foundation for hepatitis prevention and control (Tianqing liver disease research fund CFHPC20132133).

Keywords

  • Cytotoxic activity
  • Hepatocellular Carcinoma
  • NK 1.1
  • NKG2D
  • RAE1

Indexed by

  • SCIE
  • Scopus

Fingerprint

Dive into the research topics of 'Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model'. Together they form a unique fingerprint.

Cite this